# Vicarious Surgical Inc.: Form 10-K for the period ended Dec 31, 2021

- Company: [Vicarious Surgical Inc.](/companies/rbot.md) (CIK 1812173)
- Form: 10-K
- Filed: 2022-03-31
- Accepted by EDGAR: Mar 31, 2022, 16:18 ET
- Period: 2021-12-31
- Accession: 0001213900-22-016785
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1812173/000121390022016785/f10k2021_vicarioussurg.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1812173/000121390022016785/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 12 months, 2021-01-01 to 2021-12-31 | $22.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2021-01-01 to 2021-12-31 | −$38.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2021-01-01 to 2021-12-31 | $89.0k | us-gaap:InterestExpense |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | −$35.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2021-01-01 to 2021-12-31 | −$0.36 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2021-01-01 to 2021-12-31 | −$0.36 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2021-01-01 to 2021-12-31 | 96,690,716 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | −$33.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-01-01 to 2021-12-31 | $1.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2021-12-31 | $173.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-12-31 | $178.4m | us-gaap:AssetsCurrent |
| Total assets | at 2021-12-31 | $181.7m | us-gaap:Assets |
| Current liabilities | at 2021-12-31 | $6.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-12-31 | $98.6m | us-gaap:Liabilities |
| Long-term debt | at 2021-12-31 | $675.0k | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2021-12-31 | $83.1m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1812173/000121390022016785/f10k2021_vicarioussurg.htm

Filed Mar 31, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-016785. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
